BrightGene Investor
%20.jpg)
BrightGene is a biopharma company.
Total Funding:
550000000 CNY
Headquarters:
China
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
2019-01-07
Investors Number:
4
Founded Date:
2001-01-01
Industry:
Biotechnology, Health Care, Science and Engineering